On February 11, 2026, Minhui Wang increased his long position in IMMUNOTECH-B (06978) via an off-exchange transaction. The increase was effected through a waiver of rights over shares/debentures and is not a direct secondary‑market dealing.
Prior to the acquisition, Minhui Wang held 43.76 million shares, representing 7.09% of the company. Following the acquisition, the holding increased to 50.76 million shares, with the long position ratio rising to 8.22%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.